These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33169348)

  • 1. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ
    Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
    Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mucoadhesive agent inclusion on the intraocular pressure lowering profile of Δ
    Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
    Int J Pharm; 2022 Mar; 616():121564. PubMed ID: 35151817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Δ
    Taskar PS; Patil A; Lakhani P; Ashour E; Gul W; ElSohly MA; Murphy B; Majumdar S
    Transl Vis Sci Technol; 2019 Sep; 8(5):15. PubMed ID: 31588378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
    Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
    Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
    Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
    Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hypotensive drugs on the intraocular pressure after waterloading in rabbits.
    van Bijsterveld OP; van Loenen AC; ten Ham M
    Doc Ophthalmol; 1981 Dec; 52(2):189-98. PubMed ID: 6276115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.
    Kashikar R; Senapati S; Dudhipala N; Basu SK; Mandal N; Majumdar S
    J Ocul Pharmacol Ther; 2024 Jul; ():. PubMed ID: 38976488
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabidiol Loaded Topical Ophthalmic Nanoemulsion Lowers Intraocular Pressure in Normotensive Dutch-Belted Rabbits.
    Senapati S; Youssef AAA; Sweeney C; Cai C; Dudhipala N; Majumdar S
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis.
    Youssef AAA; Cai C; Dudhipala N; Majumdar S
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33802394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
    Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
    Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles.
    Halder A; Khopade AJ
    Curr Eye Res; 2021 Jul; 46(7):1031-1037. PubMed ID: 33719796
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
    Fuwa M; Ueda K; Akaishi T; Yamashita N; Kirihara T; Shimazaki A; Mano H; Kawazu K
    PLoS One; 2016; 11(7):e0158797. PubMed ID: 27383260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits.
    Loftsson T; Frithriksdóttir H; Stefánsson E; Thórisdóttir S; Guthmundsson O; Sigthórsson T
    J Pharm Pharmacol; 1994 Jun; 46(6):503-4. PubMed ID: 7932047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.